Issues

Mylan Opens New Wegovy Patent Fight

Mylan Pharmaceuticals filed a Delaware federal lawsuit seeking a declaration that its proposed generic version of Novo Nordisk's Wegovy does not infringe a patent covering administration through a single-dose pen.